Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury
- 4 November 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 388 (1) , 7-12
- https://doi.org/10.1016/j.neulet.2005.06.019
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord traumaExperimental Neurology, 2005
- WY 14643, A POTENT EXOGENOUS PPAR-?? LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCKShock, 2004
- Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex IThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator FenofibrateJournal of Biological Chemistry, 2004
- Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndromeInternational Journal of Obesity, 2004
- Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil ActivationThe Journal of Experimental Medicine, 2003
- Cyclooxygenase-2, Prostaglandin Synthases, and Prostaglandin H2Metabolism in Traumatic Brain Injury in the RatJournal of Neurotrauma, 2002
- Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in AgingJournal of Biological Chemistry, 1998
- Production of cytokines following brain injury: beneficial and deleterious for the damaged tissueMolecular Psychiatry, 1997
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996